KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Gains from Investment Securities (2016 - 2025)

Idexx Laboratories has reported Gains from Investment Securities over the past 17 years, most recently at $60000.0 for Q4 2025.

  • Quarterly results put Gains from Investment Securities at $60000.0 for Q4 2025, up 33.33% from a year ago — trailing twelve months through Dec 2025 was $7.2 million (down 31.26% YoY), and the annual figure for FY2025 was $7.2 million, down 31.26%.
  • Gains from Investment Securities for Q4 2025 was $60000.0 at Idexx Laboratories, down from $85000.0 in the prior quarter.
  • Over the last five years, Gains from Investment Securities for IDXX hit a ceiling of $15.0 million in Q1 2021 and a floor of -$31000.0 in Q2 2021.
  • Median Gains from Investment Securities over the past 5 years was $123500.0 (2022), compared with a mean of $2.7 million.
  • Biggest five-year swings in Gains from Investment Securities: plummeted 148.44% in 2021 and later surged 1127.85% in 2025.
  • Idexx Laboratories' Gains from Investment Securities stood at $61000.0 in 2021, then decreased by 11.48% to $54000.0 in 2022, then grew by 25.93% to $68000.0 in 2023, then crashed by 33.82% to $45000.0 in 2024, then soared by 33.33% to $60000.0 in 2025.
  • The last three reported values for Gains from Investment Securities were $60000.0 (Q4 2025), $85000.0 (Q3 2025), and $970000.0 (Q2 2025) per Business Quant data.